DanCann Pharma A/S
16 May - 31 May 2023Warrant exercise TO 2
DanCann Pharma is a Danish biopharmaceutical company powered by cannabinoids, licensed for production and distribution of products based on cannabinoids.
Cannabinoids is the active components from the plant cannabis. The Company conducts its business through work with both cannabis and cannabinoids as handling of the cannabis plant is part of the process in producing cannabinoids, the component used for therapeutic and medical purposes. DanCann Pharma is an early-stage company with the intention to establish itself on the European medicinal cannabis market. The Company is overall focused on discovering, developing, manufacturing, and commercializing novel cannabinoid therapeutics in a broad range of disease areas, dedicated to the commercialization of innovative prescription products targeting the European market.
The offer in summary
Subscription period: 16 May - 31 May 2023
Price per share: DKK 0.36
Trading with warrants: 16 May - 29 May 2023
The offer: 21 927 810 shares
Payment day: 31 May 2023
Market place: Spotlight Stock Market
Financial advisor: Corpura Fondkommission AB